US HR1098

Supports designating March 3, 2026, as "National Triple-Negative Breast Cancer Day" to raise awareness of the disease's impact on American families

Triple-negative breast cancer accounts for 10-15% of all breast cancer diagnoses and approximately 25% of all breast cancer deaths in the United States

The cancer disproportionately affects young women, Black and Hispanic women, and individuals with BRCA gene mutations

Triple-negative breast cancer, first recognized as a distinct cancer type in 2006, is defined by being estrogen receptor-negative, progesterone receptor-negative, and HER2-negative, making it more aggressive and likely to spread and recur